about
Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma RegistryCombined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patientsAdvanced cutaneous squamous cell carcinoma: real world data of patient profiles and treatment patternsPeripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockadePrimary Resistance to PD-1-Based Immunotherapy-A Study in 319 Patients with Stage IV MelanomaAre Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy
P50
Q89800628-C43225D9-7393-43AA-A63D-089833E2A08DQ90711858-A6C5F632-C3BA-436C-98A7-1F04ECEB43EAQ90971335-7D36DDEA-E313-4730-9A22-1C10094BADE6Q92660754-A3BE2669-7376-40D2-84F4-424451F868B4Q93210951-68C44665-EAE5-4A3F-BC74-61E36460DB07Q94471417-FA557EE2-7DCF-4DC9-8272-A628A5CBCD80Q94561146-7835EC58-FD21-4B50-B7A8-F42F6FB01844
P50
description
researcher
@en
name
T Amaral
@en
type
label
T Amaral
@en
prefLabel
T Amaral
@en
P31
P496
0000-0002-2516-5181